ArticleCancer immunology, immunotherapy : CII2021

Unique TP53 neoantigen and the immune microenvironment in long-term survivors of Hepatocellular carcinoma.

Huayu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.